,HBVPOLE3

Nobuto Kaneko1, Misao Himeno2,3, Yuhi Kobayashi1

  • 1Department of Chemistry, Graduate School of Science, The University of Tokyo 7-3-1 Hongo Bunkyo-ku Tokyo 113-0033 Japan.

RSC chemical biology
|October 30, 2025
PubMed
概括

研究人员开发了新的类迈克尔受体来治疗乙型肝炎病毒 (HBV). 化合物抑制了病毒抗原的产生和减少了病毒DNA,为HBV提供了潜在的功能治疗方法.